Article
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
Antimicrobial agents and chemotherapy - 1 Jan 2012
Chou Sunwen, Marousek Gail, Bowlin Terry L
Abstract excerpt
Human cytomegalovirus (CMV) UL54 DNA polymerase (pol) mutants with known patterns of resistance to current antivirals ganciclovir (GCV), foscarnet (FOS), and cidofovir (CDV) were tested for cyclopropavir (CPV) susceptibility by a standardized reporter-based yield reduction assay. Exonuclease and A987G (region V) mutations at codons commonly associated with dual GCV-CDV resistance in clinical isolates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
